Curaleaf (OTCMKTS:CURLF) Posts Earnings Results, Beats Expectations By $0.09 EPS

Curaleaf (OTCMKTS:CURLF) issued its quarterly earnings results on Monday. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.07) by $0.09, Zacks reports. Curaleaf had a negative return on equity of 13.67% and a negative net margin of 14.82%. The firm had revenue of $331.05 million during the quarter, compared to analysts’ expectations of $331.87 million.

Curaleaf Trading Down 12.7 %

CURLF opened at $1.03 on Wednesday. Curaleaf has a 12-month low of $0.88 and a 12-month high of $6.40. The firm’s fifty day moving average price is $1.45 and its 200 day moving average price is $2.20. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.11 and a quick ratio of 0.51. The stock has a market capitalization of $680.44 million, a PE ratio of -3.55 and a beta of 0.57.

Wall Street Analyst Weigh In

CURLF has been the topic of several recent analyst reports. Cormark lowered Curaleaf from a “moderate buy” rating to a “hold” rating in a research note on Thursday, November 7th. Roth Capital upgraded shares of Curaleaf to a “strong-buy” rating in a research note on Sunday, November 10th.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.